NCT01638507View on ClinicalTrials.gov

An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System

NACompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2015

Conditions
Coronary Artery Disease
Interventions
DEVICE

Resolute Integrity Stent

Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System

Trial Locations (1)

13203

St. Joseph's Hospital Health Center, Syracuse

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT01638507 - An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System | Biotech Hunter | Biotech Hunter